Evidence map›Paper›PMID 39095469›Full record

ArticleEye (London, England)2024

A novel variant in the keratin 12 gene in a four-generation Chinese family with high myopia.

Qinghong Lin, Xuejun Wang, Tian Han, Xiaoliao Peng, Xingtao Zhou

Abstract read
In one paragraph

Article in Eye (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qinghong Lin *Department of Ophthalmology, Eye and ENT Hospital of Fudan University, Shanghai, 200000, China.
Xuejun Wang *Department of Ophthalmology, Eye and ENT Hospital of Fudan University, Shanghai, 200000, China.
Tian HanDepartment of Ophthalmology, Eye and ENT Hospital of Fudan University, Shanghai, 200000, China.
Xiaoliao PengDepartment of Ophthalmology, Eye and ENT Hospital of Fudan University, Shanghai, 200000, China.
Xingtao ZhouDepartment of Ophthalmology, Eye and ENT Hospital of Fudan University, Shanghai, 200000, China. Linqh19870624@163.com.ORCID http://orcid.org/0000-0003-4943-7740

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh myopia is a major cause of visual impairment, and genetic factors play crucial roles in the pathogenesis. We performed this study to identify candidate genes for the development of high myopia in a four-generation Chinese family with myopia.

methodsAll family members with myopia and 100 healthy participants were included in this study. Data were obtained on demographics, disease history, and ocular examination results. We performed whole exome sequencing of the genomic DNA and Sanger sequencing to verify the variants. Functional analyses of the variant were performed using software programmes.

resultsNine of thirteen family members were found to have high myopia, amongst which two members were also diagnosed keratoconus. A missense variant in the keratin 12 gene (KRT12, p.Val410Gly) was detected in all high myopia cases but not in other family members without high myopia or the controls. The variant was predicted to be benign by online software programmes. However, modelling of the three-dimensional structure of the protein clearly revealed conformational changes caused by the mutation.

conclusionsA missense mutation in the KRT12 gene was identified in this Chinese family, which may be associated with the pathogenesis of high myopia.

Indexed as

Keratin-12Mutation, MissenseMyopia, DegenerativeAdultAgedChinaDNA Mutational AnalysisEast Asian PeopleExome SequencingFemaleHumansMaleMiddle AgedPedigreeYoung AdultKeratin-12KRT12 protein, human

Identifiers

PMID39095469
PMCPMC11584887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.